 |
|
|
Celebrity Fight Night:
122 Photo-Slideshow
CLICK HERE |
|
|
| Watch Muhammad Ali fight clips on this Parkinson's video! |
 |
|
|
| Sources used by our Parkinsons News Channel Research Team: |
| The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more |
|
| Links |
| Barrow Neurological Institute |
|
| Archives |
 |
Thursday
Comparison of Once-Daily Versus Twice-Daily Combination of Ropinirole Prolonged Release in Parkinson's Disease
Background: Ropinirole prolonged release (RPR) is a once-daily formulation. However, there may be individual pharmacokinetic differences so that multiple dosing may be preferred in some individuals. This study compares once-daily and twice-daily RPR in patients with Parkinson's disease.
Conclusions: RPR is a once-daily formulation, but multiple dosing was preferred in many patients. Multiple dosing of RPR might be a therapeutic option if once-daily dosing is unsatisfactory.
|
Celebrity Fight Night Video 
